Journal of Cancer Research and Therapeutics Close
 

Figure 3: Expression of vascular endothelial growth factor, vascular endothelial growth factor receptor, and hypoxia-inducible factor-1α (red arrow) in the animals treated using normal saline, cisplatin, low molecular weight heparin, and low molecular weight heparin plus cisplatin, respectively. The expression of vascular endothelial growth factor (a), vascular endothelial growth factor receptor (b), and hypoxia-inducible factor-1α (c) in vivo using a fluorescent microscope (Elivision Incorporation) with a magnification of ×400

Figure 3: Expression of vascular endothelial growth factor, vascular endothelial growth factor receptor, and hypoxia-inducible factor-1α (red arrow) in the animals treated using normal saline, cisplatin, low molecular weight heparin, and low molecular weight heparin plus cisplatin, respectively. The expression of vascular endothelial growth factor (a), vascular endothelial growth factor receptor (b), and hypoxia-inducible factor-1α (c) <i>in vivo</i> using a fluorescent microscope (Elivision Incorporation) with a magnification of ×400